MA32164B1 - Derive heterocyclique fusionne et son utilisation - Google Patents
Derive heterocyclique fusionne et son utilisationInfo
- Publication number
- MA32164B1 MA32164B1 MA33195A MA33195A MA32164B1 MA 32164 B1 MA32164 B1 MA 32164B1 MA 33195 A MA33195 A MA 33195A MA 33195 A MA33195 A MA 33195A MA 32164 B1 MA32164 B1 MA 32164B1
- Authority
- MA
- Morocco
- Prior art keywords
- substituents
- optionally
- fuses
- heterocyclic derivative
- compound
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Composé doté d'une activité inhibitrice supérieure de la protéine smoothend (smo) et une toxicité réduite, et qui sont suffisamment satisfaisant en tant que produit pharmaceutique. L'invention concerne un composé représenté par la formule (i) dans laquelle a représente un anneau de 5 à 7 éléments, avec un ou des substituants éventuellement reliés les uns au autres pour former un motif: x est o, s ou nr1 (r1 est un atome d'hydrogène ou un groupe hydrocarboné comportant éventuellement un ou des substituant(s); r2 est carbamoyle ayant éventuellement un ou des substituant(s) et r3 est un hydroxy ayant éventuellement un ou des substituant(s), ou bien un sel de ces composés.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008045134 | 2008-02-26 | ||
| JP2008256755 | 2008-10-01 | ||
| PCT/JP2009/054007 WO2009107850A2 (fr) | 2008-02-26 | 2009-02-25 | Dérivé hétérocyclique fusionné et son utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA32164B1 true MA32164B1 (fr) | 2011-03-01 |
Family
ID=40905094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA33195A MA32164B1 (fr) | 2008-02-26 | 2010-09-21 | Derive heterocyclique fusionne et son utilisation |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8399449B2 (fr) |
| EP (1) | EP2247588B1 (fr) |
| JP (2) | JP4719317B2 (fr) |
| KR (1) | KR101569949B1 (fr) |
| CN (1) | CN102015705B (fr) |
| AR (1) | AR070479A1 (fr) |
| AU (1) | AU2009217982B2 (fr) |
| BR (1) | BRPI0908417B1 (fr) |
| CA (1) | CA2716773C (fr) |
| CL (1) | CL2009000429A1 (fr) |
| CO (1) | CO6321277A2 (fr) |
| CR (1) | CR11661A (fr) |
| DO (1) | DOP2010000260A (fr) |
| EA (1) | EA020144B1 (fr) |
| EC (1) | ECSP10010496A (fr) |
| ES (1) | ES2586252T3 (fr) |
| GE (1) | GEP20125664B (fr) |
| IL (1) | IL207735A (fr) |
| JO (1) | JO3259B1 (fr) |
| MA (1) | MA32164B1 (fr) |
| MX (1) | MX2010009372A (fr) |
| MY (1) | MY150379A (fr) |
| NZ (1) | NZ587719A (fr) |
| PE (1) | PE20091556A1 (fr) |
| TW (1) | TWI480282B (fr) |
| WO (1) | WO2009107850A2 (fr) |
| ZA (1) | ZA201006063B (fr) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102015705B (zh) * | 2008-02-26 | 2013-11-13 | 武田药品工业株式会社 | 稠合的杂环衍生物及其用途 |
| KR101813728B1 (ko) | 2009-07-31 | 2017-12-29 | 그뤼넨탈 게엠베하 | 결정화 방법 및 생체이용률 |
| US20120277238A1 (en) * | 2009-07-31 | 2012-11-01 | Shionogi & Co., Ltd | Pharmaceutical composition containing fused hetero-ring derivative |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| EP2471793B1 (fr) | 2009-08-26 | 2016-10-05 | Takeda Pharmaceutical Company Limited | Dérivé à noyaux hétérocycliques fusionnés et son utilisation |
| US8927718B2 (en) | 2009-08-26 | 2015-01-06 | Takeda Pharmaceutical Company Limited | Fused heterocyclic ring derivative and use thereof |
| EA201270311A1 (ru) * | 2009-08-26 | 2012-09-28 | Такеда Фармасьютикал Компани Лимитед | Конденсированное гетероциклическое производное и его применение |
| EP2471789B9 (fr) * | 2009-08-26 | 2015-03-25 | Takeda Pharmaceutical Company Limited | Dérivé à noyaux hétérocycliques fusionnés et son utilisation |
| WO2012071517A2 (fr) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Nouvelles formes cristallines |
| WO2012154731A1 (fr) * | 2011-05-08 | 2012-11-15 | Vanderbilt University | Analogues de 1h-pyrrolo[3,2-c]quinoléine-4(5h)-one substitués utilisés comme modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4 |
| US20130303509A1 (en) | 2012-05-11 | 2013-11-14 | Abbvie Inc. | Nampt inhibitors |
| CN106029905B (zh) * | 2013-12-03 | 2020-04-14 | 塞雷斯特拉生命科学有限责任公司 | 基于基本原理的癌症靶向疗法的设计 |
| WO2015140964A1 (fr) | 2014-03-19 | 2015-09-24 | 株式会社 東芝 | Matériau d'électrode de batterie, batterie à électrolyte non aqueux et bloc de batteries |
| US20170015677A1 (en) * | 2014-03-31 | 2017-01-19 | Boston Biomedical, Inc. | New tricyclic quinone derivative |
| CN107709314A (zh) | 2015-06-11 | 2018-02-16 | 巴斯利尔药物国际股份公司 | 外排泵抑制剂及其治疗性用途 |
| AU2015101598A4 (en) * | 2015-09-17 | 2015-12-03 | Macau University Of Science And Technology | Novel ros1 inhibitor and its use |
| DK3412667T3 (da) * | 2016-02-01 | 2022-01-10 | Takeda Pharmaceuticals Co | Cokrystal |
| WO2017208070A1 (fr) | 2016-05-31 | 2017-12-07 | Grünenthal GmbH | Acide bisphosphonique et coformeurs avec lysine, glycine, nicotinamide pour le traitement de la polyarthrite psoriasique |
| CA3045306A1 (fr) | 2016-11-29 | 2018-06-07 | Boston Biomedical, Inc. | Derives de naphthofurane, preparation et procedes d'utilisation associes |
| JP7091201B2 (ja) | 2018-09-14 | 2022-06-27 | 株式会社東芝 | 活物質、電極、二次電池、電池パック、及び車両 |
| RU2711968C1 (ru) * | 2018-11-22 | 2020-01-24 | федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский национальный исследовательский политехнический университет" | Анальгезирующее средство |
| IL288591B2 (en) * | 2019-05-29 | 2026-05-01 | Nelum Corp | TAK-441 for use in cancer treatment in combination with other cancer therapies |
| CN110172068A (zh) * | 2019-06-05 | 2019-08-27 | 河南龙湖生物技术有限公司 | 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用 |
| EP4173639A4 (fr) | 2020-06-26 | 2024-03-13 | RaQualia Pharma Inc. | Méthode de sélection d'un patient cancéreux pour lequel une polythérapie d'un rétinoïde et d'un agent de traitement du cancer sera efficace, et médicament combiné d'un rétinoïde et d'un agent de traitement du cancer |
| CN113292477B (zh) * | 2021-06-01 | 2023-06-02 | 四川大学 | 一种铱催化的碳氢活化反应合成异吲哚-1-酮类化合物的方法 |
| CN113429422B (zh) * | 2021-07-26 | 2022-05-10 | 中国人民解放军军事科学院军事医学研究院 | 一种噻吩并喹诺酮类化合物及其制备方法和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3012684B2 (ja) | 1989-12-08 | 2000-02-28 | 大日本製薬株式会社 | チエノキノリン誘導体、チエノナフチリジン誘導体およびそれらの塩 |
| WO1993013664A2 (fr) | 1992-01-11 | 1993-07-22 | Schering Agrochemicals Limited | Composes fongicides biheterocycliques |
| FR2695126B1 (fr) * | 1992-08-27 | 1994-11-10 | Sanofi Elf | Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant. |
| JP3223289B2 (ja) | 1992-10-22 | 2001-10-29 | 東洋アルミニウム株式会社 | 肉類調理器具および肉類調理方法 |
| AU4231299A (en) | 1998-06-04 | 1999-12-20 | Abbott Laboratories | Cell adhesion-inhibiting antinflammatory compounds |
| HK1045306A1 (zh) | 1999-06-03 | 2002-11-22 | Abbott Laboratories | 抑制细胞黏附的抗炎化合物 |
| EP1217000A1 (fr) | 2000-12-23 | 2002-06-26 | Aventis Pharma Deutschland GmbH | Inhibiteurs du factor Xa et factor VIIa |
| US7998986B2 (en) | 2001-12-21 | 2011-08-16 | Exelixis Patent Company Llc | Modulators of LXR |
| AU2003265853A1 (en) | 2002-08-29 | 2004-03-19 | Curis, Inc. | Hedgehog antagonists, methods and uses related thereto |
| JP2006151810A (ja) | 2002-12-26 | 2006-06-15 | Daiichi Asubio Pharma Co Ltd | ジヒドロチエノキノリン誘導体及びそれを含む細胞接着阻害剤 |
| US20050043346A1 (en) | 2003-08-08 | 2005-02-24 | Pharmacia Italia S.P.A. | Pyridylpyrrole derivatives active as kinase inhibitors |
| EP1671962A1 (fr) | 2003-10-10 | 2006-06-21 | Ono Pharmaceutical Co., Ltd. | Nouveau compose heterocyclique fondu et utilisation correspondante |
| JPWO2005063241A1 (ja) | 2003-12-26 | 2007-07-19 | 小野薬品工業株式会社 | ミトコンドリアベンゾジアゼピン受容体介在性疾患の予防および／または治療剤 |
| NZ550222A (en) | 2004-04-08 | 2010-09-30 | Topotarget As | Diphenyl ox-indol-2-one compounds and their use in the treatment of cancer |
| GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| MX2008002165A (es) | 2005-08-16 | 2008-04-29 | Irm Llc | Compuestos y composiciones como inhibidores de la proteina cinasa. |
| AR056560A1 (es) * | 2005-10-06 | 2007-10-10 | Astrazeneca Ab | Pirrolopiridinonas como moduladores cb1 |
| PL1973910T3 (pl) * | 2006-01-27 | 2013-11-29 | Shanghai hengrui pharmaceutical co ltd | Pirolo[3,2-c]pirydyn-4-onowo-2-indolinonowe inhibitory kinazy białkowej |
| BRPI0710723A2 (pt) * | 2006-04-14 | 2012-01-31 | Novartis Ag | uso de biarilcarboxamidas no tratamento de distúrbio relacionados à série de reação hedgehog |
| BRPI0808772A2 (pt) * | 2007-03-14 | 2014-08-12 | Exelixis Inc | Inibidores da via de hedgehog |
| US8536168B2 (en) * | 2007-03-15 | 2013-09-17 | Novartis Ag | Benzyl and pyridinyl derivatives as modulators of the hedgehog signaling pathway |
| CN102015705B (zh) | 2008-02-26 | 2013-11-13 | 武田药品工业株式会社 | 稠合的杂环衍生物及其用途 |
-
2009
- 2009-02-25 CN CN2009801148111A patent/CN102015705B/zh active Active
- 2009-02-25 AU AU2009217982A patent/AU2009217982B2/en active Active
- 2009-02-25 WO PCT/JP2009/054007 patent/WO2009107850A2/fr not_active Ceased
- 2009-02-25 CA CA2716773A patent/CA2716773C/fr active Active
- 2009-02-25 NZ NZ587719A patent/NZ587719A/en unknown
- 2009-02-25 CL CL2009000429A patent/CL2009000429A1/es unknown
- 2009-02-25 EP EP09714922.3A patent/EP2247588B1/fr active Active
- 2009-02-25 GE GEAP200911952A patent/GEP20125664B/en unknown
- 2009-02-25 JP JP2010533355A patent/JP4719317B2/ja active Active
- 2009-02-25 ES ES09714922.3T patent/ES2586252T3/es active Active
- 2009-02-25 TW TW098105923A patent/TWI480282B/zh active
- 2009-02-25 BR BRPI0908417-7A patent/BRPI0908417B1/pt active IP Right Grant
- 2009-02-25 PE PE2009000279A patent/PE20091556A1/es active IP Right Grant
- 2009-02-25 KR KR1020107021331A patent/KR101569949B1/ko active Active
- 2009-02-25 MY MYPI2010004006A patent/MY150379A/en unknown
- 2009-02-25 EA EA201070994A patent/EA020144B1/ru unknown
- 2009-02-25 US US12/919,413 patent/US8399449B2/en active Active
- 2009-02-25 US US12/392,640 patent/US8217176B2/en active Active
- 2009-02-25 JO JOP/2009/0079A patent/JO3259B1/ar active
- 2009-02-25 AR ARP090100644A patent/AR070479A1/es active IP Right Grant
- 2009-02-25 MX MX2010009372A patent/MX2010009372A/es active IP Right Grant
-
2010
- 2010-08-22 IL IL207735A patent/IL207735A/en active IP Right Grant
- 2010-08-25 ZA ZA2010/06063A patent/ZA201006063B/en unknown
- 2010-08-26 DO DO2010000260A patent/DOP2010000260A/es unknown
- 2010-08-31 CR CR11661A patent/CR11661A/es unknown
- 2010-09-21 MA MA33195A patent/MA32164B1/fr unknown
- 2010-09-23 EC EC2010010496A patent/ECSP10010496A/es unknown
- 2010-09-23 CO CO10117653A patent/CO6321277A2/es active IP Right Grant
-
2011
- 2011-02-03 JP JP2011022188A patent/JP5490030B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA30524B1 (fr) | Agent de lutte antiparasite contenant un nouveau derive de pyridyl-methanamine ou un sel de celui-ci | |
| MA33851B1 (fr) | Compose heterocyclique contenant de l'azote et fongicide agricole | |
| MA34551B1 (fr) | Agent de lutte contre des organismes nuisibles | |
| TW200732333A (en) | An oxime derivative and preparations thereof | |
| EA201070994A1 (ru) | Конденсированное гетероциклическое производное и его применение | |
| CA3105662C (fr) | Composes derives de 1,3,4-oxadiazole utilises en tant qu'inhibiteur de l'histone desacetylase 6, et composition pharmaceutique les comprenant | |
| PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
| MA33581B1 (fr) | Composition pharmaceutique contenant un dérivé de quinoléine | |
| MA32911B1 (fr) | Derives de benzothiazole convenant comme agents agents anticancereux | |
| MA33159B1 (fr) | Derives de la coumarone | |
| MA26989A1 (fr) | Derives de pyridine inhibiteurs de metalloproteinases de matrice | |
| TNSN07178A1 (fr) | N-sulfonylaminobenzyl-2-phenoxy-acetamides substitues | |
| MA27885A1 (fr) | Derives de n-pyrrolidine-3-ylamide servant d'inhibiteurs de reabsorption de serotonine et de noradrenaline | |
| NO20081464L (no) | 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer | |
| MA33836B1 (fr) | Compositions pharmaceutiques contenant des ligands des récepteurs sigma | |
| MA31574B1 (fr) | Dérivés de pyrazole et leur utilisation comme inhibiteurs de raf | |
| MA29250B1 (fr) | Cyclohexylamides servant d'antagonistes des recepteurs de dopamine d3, d2 et de 5ht1a | |
| NO20062633L (no) | Pyrazolderivater som proteinkinasemodulatorer | |
| AR051780A1 (es) | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos | |
| MY153045A (en) | Oxopyrazine derivative and herbicide | |
| MA31785B1 (fr) | Nouveaux dérivés d'imidazole | |
| EA200500006A1 (ru) | Лекарственное средство для лечения нейродегенеративных заболеваний | |
| MA41790B1 (fr) | Dérivé de morphinane | |
| BR0212893A (pt) | Derivados de 4-pirimidona-3-substituìdo | |
| EA200401615A1 (ru) | ИНГИБИТОРЫ АКТИВАЦИИ NF-kB |